Navigation Links
Bacterin Becomes Premier Founding Sponsor of RMEC's New Osteobiologics Registry
Date:11/3/2011

BELGRADE, Mont., Nov. 3, 2011 /PRNewswire/ -- Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial coatings for medical applications, has become a premier founding sponsor of the Resources for Medical Education and Collaboration (RMEC) Osteobiologics Registry with an initial $100,000 unrestricted educational grant.

The goal of the Osteobiologics Registry is to develop a multi-center, longitudinal, observational registry designed to collect data surrounding the application and efficacy of osteobiologics in spinal fusion surgery, along with a mission to educate surgeons on this important topic. This effort aims to improve patient care and outcomes, reduce complications, track cost data, and identify solutions for osteobiologics in spinal procedures.

According to a statement by the RMEC: "Bacterin's support at this nascent stage is indicative of the importance of the mission and the imperative need for broad based support for data collection. Bacterin's support as a premier founding supporter is a testament to their interest in supporting the need to improve available data guiding efficacious use."

Guy Cook, CEO and chairman of Bacterin, commented: "We are excited to see a group of highly respected surgeons committed to improving the understanding of osteobiologics by founding this registry. Bacterin believes there should be better transparency in this space, and even though there are many variables that go into this type of registry, the goals and mission of this collaboration are ideally suited to the needs of the market."

The register's founding group includes five uniquely qualified clinicians and researchers in the areas of osteobiologics and orthopedics:

  • Jeffrey C. Wang, MD, professor of Orthopaedics and Neurosurgery of the UCLA School of Medicine;
  • Howard S. An, MD, The Morton Endowed Chair Professor of Orthopaedic Surgery, Director, Division of Spine Surgery, Rush University Medical Center;
  • Wellington K. Hsu, MD, assistant professor at the Northwestern University Feinberg School of Medicine;
  • Jay R. Lieberman, MD, director of the New England Musculoskeletal Institute, professor and chairman of the department of Orthopaedic Surgery at the University of Connecticut; and
  • S. Tim Yoon, MD, associate professor of orthopedic surgery at Emory University.

About RMEC

Resources for Medical Education and Collaboration (RMEC), a Colorado based 501c3, provides administrative resources to enable the development, growth, and support for the Osteobiologics Collaborative, including promoting partnerships, fundraising, and meeting organization.

RMEC was founded in 2008 and strives to improve health care quality and delivery through collaborative research and education, locally and globally through hosting medical education conferences (Evidence and Technology Spine Summit, The Osteobiologics Meeting), providing local internship opportunities, supporting research activities in clinical medicine, and bringing clinical health care and on-site medical education to developing regions of the world. In addition to founder Jim A. Youssef, MD, of Spine Colorado, RMEC's board of directors includes Darrel Brodke, MD, of the University of Utah Orthopedic Center and Paul Gervais, CPA of Durango, Colorado. Caitlyn McCullough serves as RMEC's executive director. Visit www.resourcesmec.org for more information.

About Bacterin International Holdings

Bacterin International Holdings, Inc. (NYSE Amex: BONE) develops, manufactures and markets biologics products to domestic and international markets. Bacterin's proprietary methods optimize the growth factors in human allografts to create the ideal stem cell scaffold to promote bone, subchondral repair and dermal growth. These products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery and subchondral repair in knee and other joint surgeries.

Bacterin's Medical Device division develops, employs, and licenses bioactive coatings for various medical device applications. Bacterin's strategic coating initiatives include antimicrobial coatings designed to inhibit biofilm formation and microbial contamination. For further information, please visit www.bacterin.com.

Investor Relations:
Liolios Group, Inc.
Scott Liolios or Ron Both
Tel 949-574-3860
info@liolios.com


'/>"/>
SOURCE Bacterin International Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Bacterin to Present at Lazard Capital Markets 8th Annual Healthcare Conference on November 16, 2011
2. Bacterin Sponsors the 2012 Donate Life Rose Parade Float in Recognition of Donor Families
3. Bacterin International to Present at Stifel Nicolaus 2011 Healthcare Conference on September 8, 2011
4. Bacterin Reports New Hires and Management Reorganization, Driving Most Active Processing Month in July
5. Bacterin International Signs Its Second National GPO Contract for Bacterin Biologics and Its First For Wound Drains with ROi
6. Bacterin International to Present at Noble Financial Capital Markets Seventh Annual Equity Conference on May 16, 2011
7. Bacterin International Secures $1.9 million in Private Placement
8. Bacterin International Updates Fourth Quarter and Full Year 2010 Financial Results
9. Bacterin International Signs LOI to Acquire Assets of Robinson MedSurg LLC
10. Bacterin International Holdings Secures $5,000,000 Credit Facility with Bridge Bank
11. Bacterin International Reconstitutes Its Board of Directors and Appoints Experienced Legal and Financial Professionals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Prairie, WI (PRWEB) , ... June 23, 2016 ... ... consultancy focused on quality, regulatory and technical consulting, provides a free webinar ... is presented on July 13, 2016 at 12pm CT at no charge. , ...
(Date:6/23/2016)... , June 22, 2016  Amgen (NASDAQ: ... the QB3@953 life sciences incubator to accelerate ... The shared laboratory space at QB3@953 was created to ... key obstacle for many early stage organizations - access ... the sponsorship, Amgen launched two "Amgen Golden Ticket" awards, ...
(Date:6/22/2016)... DIEGO , June 22, 2016 ... that will allow them to produce up to ... from one lot within one week. These high-quality, ... time laboriously preparing cells and spend more time ... possible through a proprietary, high-volume manufacturing process that ...
(Date:6/22/2016)... 22, 2016  According to Kalorama Information, the ... (NGS) market include significant efforts in automation as ... accessible and affordable sequencers, say the healthcare market ... consumables including sample prep materials.  The healthcare market ... Preparation for Next Generation Sequencing (NGS) , highlights ...
Breaking Biology Technology:
(Date:6/22/2016)... , June 22, 2016 On Monday, the ... to industry to share solutions for the Biometric Exit ... Customs and Border Protection (CBP), explains that CBP intends ... departing the United States , in ... to defeat imposters. Logo - http://photos.prnewswire.com/prnh/20160622/382209LOGO ...
(Date:6/20/2016)... 2016 Securus Technologies, a leading provider ... public safety, investigation, corrections and monitoring announced that ... has secured the final acceptance by all three ... Access Systems (MAS) installed. Furthermore, Securus will have ... installed by October, 2016. MAS distinguishes between legitimate ...
(Date:6/15/2016)... 2016 Transparency Market Research ... Market by Application Market - Global Industry Analysis Size Share ... the report, the  global gesture recognition market  was ... is estimated to grow at a CAGR of ... Increasing application of gesture recognition technology ...
Breaking Biology News(10 mins):